Best Oral GLP-1 Options: Approved Products and Access

Read the approved oral-product label

Wegovy tablets contain semaglutide; Foundayo contains orforglipron. Each has its own label, precautions and administration instructions. Ask the prescriber which exact finished product fits the treatment purpose instead of transferring instructions from another medicine.

Ask the provider about actual availability

A provider’s general therapy menu does not establish that it currently prescribes, dispenses or stocks every oral option. Request the exact product, pharmacy and written quote, including whether an appointment or program fee is billed separately.

Separate pill and injection comparisons

An injectable compounded quote is not a valid price quote for an approved tablet. The featured prices below refer to the reviewed injectable offers only. Compare a prescribed oral product with its actual pharmacy price and care fees.

What the starting price leaves to confirm

CoreAge’s supplied annual semaglutide quote is $79 per month, or $948 across twelve months; tirzepatide is $129 per month, or $1,548. Its public product pages separately display $99 and $149 starting figures. SuperHealthy’s linked promotion displays $85 and $135; Likeness publishes multiple terms. Confirm which current offer the written order actually covers.

Save the complete payment, supplied quantity, renewal date and cancellation method. CoreAge’s policy includes possible non-refundable consultation fees. SuperHealthy describes optional automatic refill, while Likeness describes automatic renewal of the selected term. These are materially different arrangements even when two monthly figures look similar.

Questions for the assessment

• Which approved oral product is being considered?
• Does this service currently support that exact prescription?
• What are its product-specific instructions and full pharmacy cost?

Approved products and compounded offers

The featured offers reviewed here concern compounded preparations, which are not FDA-approved. Ask whether an approved product could meet the medical need and what individual rationale supports a compounded alternative. This page does not verify prescription eligibility, pharmacy quality or patient outcomes, and it does not provide a dosing plan.